|Event Date||Tue Oct 5 EDT - Wed Oct 6 EDT (9 months ago)|
Due to the pandemic we have decided that for the second time Sachs Basel events will be held in a digital format, thus allowing us to support our community and past attendees. We will provide both the usual stimulating programme and the networking opportunities through the online meeting system. We are constantly reviewing the situation and circumstances permitting, plan to announce in June that part of the Sachs Autumn Life Sciences Week programme will be delivered physically in Basel on the 7th and 8th of October. This would include live speeches and presentations as part of the 21st BEF with in person meetings and the event reception for both events. We will update all those who registered and when registering please indicate by ticking the appropriate box whether you would be interested in attending in person. Updates on any possible hybrid format will be posted on this website.
The main programme for the 8th Annual HTIF is spread throughout 2 days (5th-6th of October) and will include HealthTech Innovation Day, focusing on Investment & Partnership in MedTech and Digital Health, and Managing Covid-19 Pandemic & Future Global Threats Day, which will include keynotes covering global supply chain and diagnostics. The two days will feature more than 12 hours of high-level speeches, panel discussions and spotlight showcases by leading industry corporates. In addition, there is a global company showcase of 25+ presentations by established public, private, emerging and seed companies, offering innovative solutions and are seeking investment and partnering opportunities. We anticipate 300+ delegates drawn from Digital Health, MedTech/Device companies, banks, investors and advisors.
CONFIRMED KEYNOTE SPEAKERS:
Deputy Director General, CMO & CIO, Sheba Medical Center
Sir Menelas N. Pangalos
Executive Vice-President, R&D BioPharmaceuticals, AstraZeneca
CONFIRMED SPEAKERS & CHAIRS INCLUDE:
Alan Carr, Contractor
Tunnell Government Services
Partner, Novo Holdings A/S
Head, Vice President, Infectious Disease Research, Moderna, Inc.
Global Head Digital BD&L, Novartis International AG
Senior Partner, Truffle Capital
Partner, Oliver Wyman INC.
Independent - BM
Chairman & CEO, Humanigen, Inc.
Investment Manager, Takeda Digital Ventures LP
CEO, C4X Discovery Holdings PLC
CFO & COO, Pear Therapeutics, Inc.
Global Head of Connected Health & Devices Business Solutions, Merck
Co-Founder & General Partner, Panakès Partners SGR SpA
Chief of Research & Development, CARB-X
CEO, Galil Ofek Innovation
Owner, Philimmune, LLC
EMEA Lead, Healthcare & Life Sciences Startups, Amazon Web Services
CEO, AMR Action Fund GP
Senior Associate, Gilde Healthcare Partners
CEO, Sequana Medical NV
Managing Partner, Pitango Venture Capital
Head of Health, AXA Assistance
Managing Director, Equity Research, Healthcare & Medical Technologies, Ladenburg Thalmann & Co. Inc.
Principal, Seroba Life Sciences
Co-Founder & COO, Sonde Health
Johan Van Hoof
Global Therapeutic Area Head of ID & Vaccines & Managing Director, Janssen Vaccines & Prevention B.V.
Director, Global Tech Partnerships, Boston Scientific
President & CEO, Arcturus Therapeutics, Inc.
Managing Partner, LSP (Life Sciences Partners)
Co-Founder & Managing Partner, Peppermint VenturePartners GmbH
Director of Business Creation, EIT Health e.V.
Managing Partner, Cukierman & Co. Life Sciences
Partner, Earlybird Venture Capital
CBO, FutuRx Ltd.
President & CEO, PIXIUM VISION SA
BU Director Respiratory & Immunology, AstraZeneca
Managing Director, PharmaVentures Ltd.
CFO, BioVersys AG
Principal, High-Tech Gründerfonds Management GmbH
Managing Director, Stifel Financial Corp.
President & CEO, Qpex Biopharma, Inc.
CEO, Oxford Endovascular Ltd.
Senior Director, Scientific & Medical Affairs, Medicago
Head of Vaccine Programs and Technology for R&D, Coalition for Epidemic Preparedness Innovations (CEPI)
VP Business Development, eHealth Ventures LP
Investment Director, Industrifonden
Co-Founder, CoviCept Therapeutics, LLC
Managing Partner, Wellington Partners
CEO, Synairgen Research Ltd.
Professor of Mucosal Infection & Immunity, Imperial College London
Founder & CEO, Alveo Technologies
Managing Director, aMoon Fund
Head of EMEA Business Development, Olympus Europa SE & Co. KG
Head of Business Development, Otsuka Pharmaceutical Co., Ltd.
Sander van Deventer
Operating Partner, Forbion
Thijs Cohen Tervaert
Junior Partner, INKEF Capital BV
CSO & Board Director, Vaccitech Ltd.
Managing Director & Healthcare Analyst, BTIG, LLC
Timothy Herpin, VP, Business Development
Infectious Diseases & Vaccines, Johnson & Johnson Innovation | Janssen Business Development
Chief Business Officer, Venatorx Pharmaceuticals
CEO, ExeVir Bio BV
Founder & Managing Director, GrowthCube Partners LLC
Venture Capital Investor, Draper Esprit
Co-Founder & CMO, docdok.health Ltd.
• EIT HEALTH E.V.
• PHARMAVENTURES LTD.
• FREEMIND GROUP
• INSTINCTIF PARTNERS
• PLATTFORM LIFE SCIENCES
• SWISS BIOTECH ASSOCIATION
• TIBEREND STRATEGIC ADVISORS, INC.